disopyramide has been researched along with Agranulocytosis in 1 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conrad, ME | 1 |
| Cumbie, WG | 1 |
| Thrasher, DR | 1 |
| Carpenter, JT | 1 |
1 other study available for disopyramide and Agranulocytosis
| Article | Year |
|---|---|
Agranulocytosis associated with disopyramide therapy.
Topics: Agranulocytosis; Arrhythmias, Cardiac; Disopyramide; Drug Hypersensitivity; Humans; Male; Middle Age | 1978 |